Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer
CAMBRIDGE, Mass., June 24, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better...
CAMBRIDGE, Mass., June 24, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better...
CRISPR Therapeutics AG-More than 25 authorized treatment centers (ATCs) activated globally for CASGEVY™ and multiple patients have already had cells...